Host: |
Goat |
Applications: |
Pep-ELISA/WB/IHC |
Reactivity: |
Human/Mouse/Rat/Dog/Pig/Cow |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-NEFM/NF-M (Internal) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Concentration: |
0.5 mg/mL |
Dilution Range: |
WB-0.03-0.1µg/mlIHC-5µg/mlELISA-antibody detection limit dilution 1:128000. |
Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
Gene Symbol: |
NEFM |
Gene ID: |
4741 |
Uniprot ID: |
NFM_HUMAN |
Immunogen Region: |
Internal |
Accession Number: |
NP_005373.2 |
Specificity: |
This antibody is expected to recognize reported isoform 1 (NP_005373.2) only. |
Immunogen Sequence: |
QASHITVERKDYLK |
Function | Neurofilaments usually contain three intermediate filament proteins: NEFL, NEFM, and NEFH which are involved in the maintenance of neuronal caliber. May additionally cooperate with the neuronal intermediate filament proteins PRPH and INA to form neuronal filamentous networks. |
Protein Name | Neurofilament Medium PolypeptideNf-M160 Kda Neurofilament ProteinNeurofilament 3Neurofilament Triplet M Protein |
Cellular Localisation | CytoplasmCytoskeletonCell ProjectionAxon |
Alternative Antibody Names | Anti-Neurofilament Medium Polypeptide antibodyAnti-Nf-M antibodyAnti-160 Kda Neurofilament Protein antibodyAnti-Neurofilament 3 antibodyAnti-Neurofilament Triplet M Protein antibodyAnti-NEFM antibodyAnti-NEF3 antibodyAnti-NFM antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance